Jeffrey Moe, Henry Grabowski, David Ridley. Show Affiliations »
Abstract
Mesh： See more » Cost-Benefit AnalysisDeveloping CountriesDrug Approval/economicsDrug Approval/legislation & jurisprudenceDrug Industry/economicsHumansParasitic Diseases/drug therapySafetyTropical MedicineUnited StatesUnited States Food and Drug Administration
Year: 2009 PMID： 19228632 DOI： 10.1056/NEJMc086492
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245